Information if you call out the disease or condition the drug treats in a text ad. This has caused some problems for the pharmaceutical industry trying to make a text ad relevant to a search query. If someone was looking for heart failure medicine and you wanted to include the term “heart failure medicine” in your ad, you couldn't unless you disclosed the risks or removed the name. drug brand. With Google and Bing displaying the destination URL in ads – which was often branded – this caused a big problem for branded ads. To work around this problem, Google and
Bing previously allowed pharmaceutical brands to use vanity URLs. These were basically unbranded URLs that redirected to a branded website. For example, www.heartfailuremeds.com redirects to www.brand.com. This way, the ad would not show the jewelry retouching service brand name but would instead show www.heartfailuremeds.com. This practice, of course, is against the regulations for all advertisers outside of the pharmaceutical industry. In early 2016, Google removed this option, as they called the practice misleading for searchers. Now,
advertisers can use a select set of "display URL options". Currently, pharmaceutical advertisers can choose from the following options in AdWords: Website Descriptions It was a hot topic in the SEM community in 2016, as many PPC experts were surprised that Google allowed advertisers to run something not available to any other industry. The legal review process Every pharmaceutical company has an internal legal and regulatory team to review a myriad of materials. From websites and office brochures to SEM videos and ads,